Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
 
 
Email
mdccwj@nus.edu.sg
 
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Date Issued:  [2010 TO 2019]
Date Issued:  2019

Results 1-17 of 17 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
11-Nov-2019Comprehensive Analysis of ERK1/2 Substrates for Potential Combination ImmunotherapiesYang, Lei ; Zheng, Liangzhen; Chng, Wee Joo ; Ding, Jeak Ling 
22019Epigenetic silencing of miR-340-5p in multiple myeloma: Mechanisms and prognostic impactLi, Z.; Wong, K.Y.; Calin, G.A.; Chng, W.-J. ; Chan, G.C.-F.; Chim, C.S.
32019EZH2 abnormalities in lymphoid malignancies: Underlying mechanisms and therapeutic implicationsLi, B. ; Chng, W.-J. 
415-Sep-2019IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple MyelomaChong, Phyllis SY ; Zhou, Jianbiao ; Lim, Julia SL ; Hee, Yan Ting; Chooi, Jing-Yuan ; Chung, Tae-Hoon ; Tan, Zea Tuan ; Zeng, Qi ; Waller, Daniel D; Sebag, Michael; Chng, Wee-Joo 
52-Dec-2019Liquid biopsy for minimal residual disease detection in leukemia using a portable blast cell biochipKhoo, Bee Luan; Shang, Menglin; Ng, Chin Hin; Lim, Chwee Teck ; Chng, Wee Joo ; Han, Jongyoon
65-Dec-2019MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphomaLi, Boheng ; Yan, Junli ; The, Phyu; Fan, Shuangyi ; Chung, Tae-Hoon; Mustafa, Nurulhuda; Lin, Baohong; Wang, Lingzhi ; Eichhorn, Pieter Johan Adam; Goh, Boon-Cher ; Ng, Siok-Bian ; Kappei, Dennis; Chng, Wee-Joo 
72-Apr-2019Molecular pathogenic pathways in extranodal NK/T cell lymphomade Mel, Sanjay; Hue, Susan Swee-Shan; Jeyasekharan, Anand D ; Chng, Wee-Joo ; Ng, Siok-Bian 
828-Feb-2019Non-canonical activation of beta-catenin by PRL-3 phosphatase in acute myeloid leukemiaChong, Phyllis SY ; Zhou, Jianbiao ; Chooi, Jing-Yuan ; Chan, Zit-Liang; Toh, Sabrina Hui Min ; Tan, Tuan Zea ; Wee, Sheena; Gunaratne, Jayantha ; Zeng, Qi ; Chng, Wee-Joo 
924-Sep-2019Novel mechanism of drug resistance to proteasome inhibitors in multiple myeloma.Zhou, Jianbiao ; Chng, Wee-Joo 
108-Oct-2019Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma NetworkSoekojo, Cinnie Yentia; Kim, Kihyun; Huang, Shang-Yi; Chim, Chor-Sang; Takezako, Naoki; Asaoku, Hideki; Kimura, Hideo; Kosugi, Hiroshi; Sakamoto, Junichi; Gopalakrishnan, Sathish Kumar; Nagarajan, Chandramouli; Wei, Yuan; Moorakonda, Rajesh; Lee, Shu Ling; Lee, Je Jung; Yoon, Sung-Soo; Kim, Jin Seok; Min, Chang Ki; Lee, Jae-Hoon; Durie, Brian; Chng, Wee Joo 
112019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
122019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
131-May-2019STAT3: A Promising Therapeutic Target in Multiple MyelomaChong, Phyllis SY ; Chng, Wee-Joo ; de Mel, Sanjay
142019Super-enhancers: Critical roles and therapeutic targets in hematologic malignanciesJia, Y.; Chng, W.-J. ; Zhou, J. 
151-Jul-2019The Contribution of MYC and PLK1 Expression to Proliferative Capacity in Diffuse Large B-Cell LymphomaMing Liang Oon; Michal Hoppe ; Shuangyi Fan ; The Phyu ; Hoang Phuong ; Soo Yong Tan ; Susan Swee-Shan Hue ; Shi Wang ; Li Mei Poon ; Esther Chan ; Joanne Lee; Yen Lin Chee ; Wee Joo Chng ; Sanjay de Mel; Xin Liu; Anand Jeyasekharan ; Siok Bian Ng 
168-Jan-2019Towards understanding of PRC2 binding to RNAJunli Yan ; Bibek Dutta; Yan Ting Hee; Wee Joo Chng 
1717-Jan-2019Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disordersde Mel, Sanjay; Tan, Joshua Zhi-Chien; Jeyasekharan, Anand D ; Chng, Wee-Joo ; Ng, Siok-Bian